The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Baldry Mark since 2023.
This trader's CIK number is 1644137.
At the time of last reporting, Baldry Mark was the Chief Commercial Officer of X4 Pharmaceuticals, Inc. (stock ticker symbol XFOR).
Also see all insider trading activities at X4 Pharmaceuticals, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | XFOR | 1,032 | $2,561 | 29,159 | $13,238 | 0 | $0 |
| 2024 | XFOR | 0 | $0 | 11,127 | $6,509 | 0 | $0 |
| 2023 | XFOR | 0 | $0 | 10,257 | $7,487 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-16 | XFOR | Buy | 1,032 | 2.48 | 2,561 |
| 2025-01-24 | XFOR | Sale | 29,159 | .45 | 13,238 |
| 2024-10-07 | XFOR | Sale | 11,127 | .58 | 6,509 |
| 2023-11-01 | XFOR | Sale | 10,257 | .73 | 7,487 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Baldry Mark (Chief Commercial Officer of X4 Pharmaceuticals, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.